Nanobiotix (NBTX)

Nanobiotix (NBTX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $1.7B; returns 1 day +0.6%, 1 week +37.8%, 1 year +52.3%.

Nanobiotix is a clinical-stage biotechnology company pioneering physics-based nanomedicines, primarily focused on oncology.

Groups NBTX belongs to

• Biotechnology
• Oncology
• Clinical Stage
• Clinical Stage Biotech
• Healthcare
• Life Sciences
• Biopharmaceutical
• Cancer Therapeutics
• Precision Medicine
• Immunotherapy

NBTX financial model: income statement, cash flow and balance sheet